drugset / Trial / NCT07333261
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
This is a phase 1b study evaluating if BMS-986453 is safe and effective in treating people who have newly diagnosed multiple myeloma after completing initial therapy (induction) when a stem cell transplant is not intended.
Timeline
- Start
- 2026-02-09
- Primary completion
- 2031-12
- Completion
- 2041-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986453 | Unknown | — | Intravenous |